Bookmark
Forward
Explore Literature Results
QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=DBD095BCCA38433041347AA587F55A81;jsessionid=A1E308CF1FD395834B52B6503334BEEC;jsessionid=AD3CB27D4823922847293BABAFED6FFF;jsessionid=160137F7EEDBA1440C257E085079BBAB;jsessionid=5DC4D79984CD1ACF2D76C2DBF60687E4;jsessionid=3F4B55877058B14FD3E6D7AFBA8B7638;jsessionid=40CDF2523210D0FA1A78E5F828A849B8;jsessionid=19C94D2F4C6FBFB942ED091DD9D8B935;jsessionid=A06EDC4ECCC13CAF51D09079E4677775;jsessionid=1601A7DD7F54942967BF45F6CAD422C1;jsessionid=4D4640F055E6F5EFB0E74EF8AF1D6F92;jsessionid=45812EBC62C5D7E67F7667B5090F69D5;jsessionid=EDAB59E14D8FB4CE54A526605D5ED074 (gene)
Most Correlated Tissues
Task java.util.concurrent.FutureTask@35d6f873 rejected from java.util.concurrent.ThreadPoolExecutor@527b86ce[Running, pool size = 100, active threads = 100, queued tasks = 0, completed tasks = 20333923]
Explore Body Atlas Results
Most Relevant Literature
- Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
- Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
- Stability of varicella-zoster virus open reading frame 63.
- Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
- Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…
Most Relevant Clinical Trials
There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=DBD095BCCA38433041347AA587F55A81;jsessionid=A1E308CF1FD395834B52B6503334BEEC;jsessionid=AD3CB27D4823922847293BABAFED6FFF;jsessionid=160137F7EEDBA1440C257E085079BBAB;jsessionid=5DC4D79984CD1ACF2D76C2DBF60687E4;jsessionid=3F4B55877058B14FD3E6D7AFBA8B7638;jsessionid=40CDF2523210D0FA1A78E5F828A849B8;jsessionid=19C94D2F4C6FBFB942ED091DD9D8B935;jsessionid=A06EDC4ECCC13CAF51D09079E4677775;jsessionid=1601A7DD7F54942967BF45F6CAD422C1;jsessionid=4D4640F055E6F5EFB0E74EF8AF1D6F92;jsessionid=45812EBC62C5D7E67F7667B5090F69D5;jsessionid=EDAB59E14D8FB4CE54A526605D5ED074
Explore Clinical Trials Results
